Integrating Immunometabolism and Chronic Inflammation: A Systems-Based Approach to Multimorbidity in Internal Medicine

Authors

DOI:

https://doi.org/10.64784/155

Keywords:

immunometabolism, chronic inflammation, metaflammation, insulin resistance, obesity, metabolic syndrome, atherosclerosis, multimorbidity, gut microbiota, inflammaging, internal medicine, systems-based medicine

Abstract

Chronic diseases in internal medicine have traditionally been approached as isolated entities; however, emerging evidence supports their interpretation as interconnected processes sustained by metabolic–inflammatory networks. This review aimed to analyze and integrate current high-impact evidence on immunometabolism, chronic inflammation, and systemic dysregulation in order to propose a systems-based framework applicable to clinical practice and medical education. A structured narrative review was conducted using 20 peer-reviewed references indexed in major biomedical databases. The analysis focused on key mechanisms including metaflammation, insulin resistance, adipose tissue inflammation, vascular dysfunction, gut microbiota interactions, skeletal muscle signaling, and ageing-related inflammatory changes. The results demonstrated a consistent convergence across mechanistic, biological, and clinical domains, highlighting chronic inflammation as a central driver linking obesity, type 2 diabetes mellitus, atherosclerosis, and multimorbidity. Furthermore, the evidence revealed that these processes are dynamically influenced by lifestyle factors, environmental exposures, and ageing. The integration of these findings supports a network-based model of disease that transcends traditional organ-specific approaches. This framework offers potential benefits in clinical reasoning, risk stratification, preventive strategies, and medical education, particularly in regions with a high burden of chronic disease such as Mexico, Colombia, and Ecuador. In conclusion, metabolic–inflammatory networks represent a fundamental organizing principle in chronic disease, providing a coherent and clinically relevant perspective for modern internal medicine.

References

1. Calder, P. C., Ahluwalia, N., Brouns, F., Buetler, T., Clement, K., Cunningham, K., … Winklhofer-Roob, B. M. (2011). Dietary factors and low-grade inflammation in relation to overweight and obesity. British Journal of Nutrition, 106(S3), S5–S78. https://doi.org/10.1017/S0007114511005460

2. DeFronzo, R. A., Ferrannini, E., Groop, L., Henry, R. R., Herman, W. H., Holst, J. J., … Weiss, R. (2015). Type 2 diabetes mellitus. Nature Reviews Disease Primers, 1, 15019. https://doi.org/10.1038/nrdp.2015.19

3. Donath, M. Y., & Shoelson, S. E. (2011). Type 2 diabetes as an inflammatory disease. Nature Reviews Immunology, 11(2), 98–107. https://doi.org/10.1038/nri2925

4. Franceschi, C., Garagnani, P., Parini, P., Giuliani, C., & Santoro, A. (2018). Inflammaging: A new immune–metabolic viewpoint for age-related diseases. Nature Reviews Endocrinology, 14(10), 576–590. https://doi.org/10.1038/s41574-018-0059-4

5. Furman, D., Campisi, J., Verdin, E., Carrera-Bastos, P., Targ, S., Franceschi, C., … Slavich, G. M. (2019). Chronic inflammation in the etiology of disease across the life span. Nature Medicine, 25(12), 1822–1832. https://doi.org/10.1038/s41591-019-0675-0

6. Gregor, M. F., & Hotamisligil, G. S. (2011). Inflammatory mechanisms in obesity. Annual Review of Immunology, 29, 415–445. https://doi.org/10.1146/annurev-immunol-031210-101322

7. Hotamisligil, G. S. (2017). Inflammation, metaflammation and immunometabolic disorders. Nature, 542(7640), 177–185. https://doi.org/10.1038/nature21363

8. Kotas, M. E., & Medzhitov, R. (2015). Homeostasis, inflammation, and disease susceptibility. Cell, 160(5), 816–827. https://doi.org/10.1016/j.cell.2015.02.010

9. Libby, P. (2021). The changing landscape of atherosclerosis. Nature, 592(7855), 524–533. https://doi.org/10.1038/s41586-021-03392-8

10. Monteiro, R., & Azevedo, I. (2010). Chronic inflammation in obesity and the metabolic syndrome. Mediators of Inflammation, 2010, 289645. https://doi.org/10.1155/2010/289645

11. O’Neill, L. A. J., Kishton, R. J., & Rathmell, J. (2016). A guide to immunometabolism for immunologists. Nature Reviews Immunology, 16(9), 553–565. https://doi.org/10.1038/nri.2016.70

12. Pedersen, B. K., & Febbraio, M. A. (2012). Muscles, exercise and obesity: Skeletal muscle as a secretory organ. Nature Reviews Endocrinology, 8(8), 457–465. https://doi.org/10.1038/nrendo.2012.49

13. Pickup, J. C. (2004). Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care, 27(3), 813–823. https://doi.org/10.2337/diacare.27.3.813

14. Reilly, S. M., & Saltiel, A. R. (2017). Adapting to obesity with adipose tissue inflammation. Nature Reviews Endocrinology, 13(11), 633–643. https://doi.org/10.1038/nrendo.2017.90

15. Ridker, P. M. (2016). From C-reactive protein to interleukin-6 to interleukin-1: Moving upstream to identify novel targets for atheroprotection. Circulation Research, 118(1), 145–156. https://doi.org/10.1161/CIRCRESAHA.115.306656

16. Saltiel, A. R., & Olefsky, J. M. (2017). Inflammatory mechanisms linking obesity and metabolic disease. Journal of Clinical Investigation, 127(1), 1–4. https://doi.org/10.1172/JCI92035

17. Scheithauer, T. P. M., Rampanelli, E., Nieuwdorp, M., Vallance, B. A., Verchere, C. B., van Raalte, D. H., & Herrema, H. (2020). Gut microbiota as a trigger for metabolic inflammation in obesity and type 2 diabetes. Frontiers in Immunology, 11, 571731. https://doi.org/10.3389/fimmu.2020.571731

18. Tilg, H., & Moschen, A. R. (2010). Inflammatory mechanisms in the regulation of insulin resistance. Molecular Medicine, 14(3–4), 222–231. https://doi.org/10.2119/2007-00119.Tilg

19. Tilg, H., Zmora, N., Adolph, T. E., & Elinav, E. (2020). The intestinal microbiota fuelling metabolic inflammation. Nature Reviews Immunology, 20(1), 40–54. https://doi.org/10.1038/s41577-019-0198-4

20. Wang, A., Luan, H. H., & Medzhitov, R. (2019). An evolutionary perspective on immunometabolism. Science, 363(6423), eaar3932. https://doi.org/10.1126/science.aar3932

Downloads

Published

2026-04-01

How to Cite

Integrating Immunometabolism and Chronic Inflammation: A Systems-Based Approach to Multimorbidity in Internal Medicine (César Eduardo Ceja Tovar, Jorge Che Enseñat, María Alejandra Chauran, Uslar Gibran Díaz Maestre, Fatima Itzel Soto Rios, Raphaela Ballon Chehade, Martin Gomez-Lujan, & Arianna Kamila Vargas Calapaqui, Trans.). (2026). IECCMEXICO, 4(3). https://doi.org/10.64784/155